These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 8797111

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
    Kaji H, Sugimoto T, Kanatani M, Fukase M, Kumegawa M, Chihara K.
    J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
    [Abstract] [Full Text] [Related]

  • 3. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity.
    Kanatani M, Sugimoto T, Kaji H, Kobayashi T, Nishiyama K, Fukase M, Kumegawa M, Chihara K.
    J Bone Miner Res; 1995 Nov; 10(11):1681-90. PubMed ID: 8592944
    [Abstract] [Full Text] [Related]

  • 4. Stimulatory effect of insulin-like growth factor binding protein-5 on mouse osteoclast formation and osteoclastic bone-resorbing activity.
    Kanatani M, Sugimoto T, Nishiyama K, Chihara K.
    J Bone Miner Res; 2000 May; 15(5):902-10. PubMed ID: 10804020
    [Abstract] [Full Text] [Related]

  • 5. Dexamethasone stimulates osteoclast-like cell formation by directly acting on hemopoietic blast cells and enhances osteoclast-like cell formation stimulated by parathyroid hormone and prostaglandin E2.
    Kaji H, Sugimoto T, Kanatani M, Nishiyama K, Chihara K.
    J Bone Miner Res; 1997 May; 12(5):734-41. PubMed ID: 9144339
    [Abstract] [Full Text] [Related]

  • 6. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M, Sugimoto T, Kano J, Kanzawa M, Chihara K.
    J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
    [Abstract] [Full Text] [Related]

  • 7. Stimulatory effect of growth hormone on bone resorption and osteoclast differentiation.
    Nishiyama K, Sugimoto T, Kaji H, Kanatani M, Kobayashi T, Chihara K.
    Endocrinology; 1996 Jan; 137(1):35-41. PubMed ID: 8536635
    [Abstract] [Full Text] [Related]

  • 8. Effects of high calcium concentration on the functions and interactions of osteoblastic cells and monocytes and on the formation of osteoclast-like cells.
    Sugimoto T, Kanatani M, Kano J, Kaji H, Tsukamoto T, Yamaguchi T, Fukase M, Chihara K.
    J Bone Miner Res; 1993 Dec; 8(12):1445-52. PubMed ID: 8304045
    [Abstract] [Full Text] [Related]

  • 9. Carboxyl-terminal parathyroid hormone fragments stimulate osteoclast-like cell formation and osteoclastic activity.
    Kaji H, Sugimoto T, Kanatani M, Miyauchi A, Kimura T, Sakakibara S, Fukase M, Chihara K.
    Endocrinology; 1994 Apr; 134(4):1897-904. PubMed ID: 8137758
    [Abstract] [Full Text] [Related]

  • 10. Involvement of dual signal transduction systems in the stimulation of osteoclast-like cell formation by parathyroid hormone and parathyroid hormone-related peptide.
    Kaji H, Sugimoto T, Kanatani M, Fukase M, Chihara K.
    Biochem Biophys Res Commun; 1993 Jul 15; 194(1):157-62. PubMed ID: 8392835
    [Abstract] [Full Text] [Related]

  • 11. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells.
    Jimi E, Nakamura I, Duong LT, Ikebe T, Takahashi N, Rodan GA, Suda T.
    Exp Cell Res; 1999 Feb 25; 247(1):84-93. PubMed ID: 10047450
    [Abstract] [Full Text] [Related]

  • 12. Regucalcin stimulates osteoclast-like cell formation in mouse marrow cultures.
    Yamaguchi M, Uchiyama S.
    J Cell Biochem; 2005 Mar 01; 94(4):794-803. PubMed ID: 15578574
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Insulin-like growth factor-I mediates osteoclast-like cell formation stimulated by parathyroid hormone.
    Kaji H, Sugimoto T, Kanatani M, Nishiyama K, Nasu M, Chihara K.
    J Cell Physiol; 1997 Jul 01; 172(1):55-62. PubMed ID: 9207925
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.
    Kanatani M, Sugimoto T, Sowa H, Kobayashi T, Kanzawa M, Chihara K.
    J Cell Physiol; 2004 Oct 01; 201(1):17-25. PubMed ID: 15281085
    [Abstract] [Full Text] [Related]

  • 17. Carboxyl-terminal peptides from parathyroid hormone-related protein stimulate osteoclast-like cell formation.
    Kaji H, Sugimoto T, Kanatani M, Fukase M, Chihara K.
    Endocrinology; 1995 Mar 01; 136(3):842-8. PubMed ID: 7867592
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.
    Ishida M, Amano S.
    J Bone Miner Metab; 2004 Mar 01; 22(5):415-29. PubMed ID: 15316862
    [Abstract] [Full Text] [Related]

  • 20. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
    van't Hof RJ, Ralston SH.
    J Bone Miner Res; 1997 Nov 01; 12(11):1797-804. PubMed ID: 9383684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.